Company news

Premier Biomedical Inc news in 2016

Premier Biomedical Inc's news releases, calls and decks from 2016, newest first.

View company

Premier Biomedical, Inc. CEO Letter - December, 2017

December 15, 2016

Premier Biomedicals Research on its Patent Pending Anti-Cancer Treatment With Metronomic Chemotherapy Recognized for Publication in the Prestigious British Journal of Cancer

December 6, 2016

Premier Biomedical Pain Management Solutions Reports Outstanding Results in Pre-Production Pain Patch Trials Conducted by Medical Professionals

November 16, 2016

Premier Biomedical Pain Management Solutions Executives Advance Plans for an Array of Opioid-Free New Products to Compete in $112 Billion Global Pain Market Beginning January 2017

November 9, 2016

Premier Biomedical, Inc. CEO Letter, October 2016 - Quarterly Corporate Update

October 6, 2016

Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch

September 27, 2016

Premier Biomedical and Advanced Technologies Solutions Form Pain Management Joint Venture to Treat Generalized, Neuropathic and Localized Pain With Natural Cannabis-Based Products

September 15, 2016

Premier Biomedical Appoints Dr. Patricio Reyes to Board and Chief Technical Officer

August 22, 2016

Premier Biomedical and Advanced Technologies Solutions Agree to Forming Joint Venture in Pain Management, Treating Neuropathic and Localized Pain

August 1, 2016

Premier Biomedical, Inc. CEO Letter, July, 2016 Updates and Progress on Partnership Initiatives for Specialty Diseases and Anti-Cancer Drugs Research

July 18, 2016

Premier Biomedical Anti-Cancer Antibody Outperforms Leading Multi-Billion Dollar Commercial Cancer Treatments in Initial Head-to-Head Testing at a Major University

July 6, 2016

Premier Biomedical Confirms Consolidation of Debt

May 31, 2016

Premier Biomedical Announces the Appointment of Dr. James Frincke to Chief Technical Officer Position

May 24, 2016

Premier Biomedical, Inc. Cancer Immunotherapy Research Highlights to Be Presented at AACR Conference

April 11, 2016

Premier Biomedical, Inc. Engages Agent to Identify Suitable Joint Venture Partners in China and Europe

March 16, 2016

Premier Biomedical, Inc. Engages Agent in India to Identify Suitable Joint Venture Partners in Asia

March 8, 2016

Zika Virus Suspected To Be Transmitted Sexually; Premier Biomedical Inc. Increases Focus; Optimistic Their Patented Extracorporeal Methodology Could Be Most Effective Treatment

February 25, 2016

Premier Biomedical Inc. Optimistic Their Patented Methodology Will Be Effective In Treating Dengue and Zika Virus

February 16, 2016

Premier Biomedical, Inc. Releases Video "A Scientific Roadmap to Cure Cancer"

February 8, 2016

Premier Biomedical Announces Intended $6 Million Investment by Brazilian Joint Venture Partner, Auramedi, to Manufacture, Market and Distribute Premier’s New Technology Products

February 1, 2016

Premier Biomedical Files Provisional Patent Application on Second Drug to Treat Fibromyalgia, Neuropathic Pain, MS Symptoms, and Alcohol and Chemical Addiction

January 26, 2016

Premier Biomedical CEO in Radio Interview Discusses Core Technology, Immunotherapy, Neuropathy Medication and Planned Series of Joint Ventures in Brazil, Asia and Europe for 2016

January 19, 2016

Broad-Based Patent Involving Innovative Extracorporeal Treatment Therapy Issued – Premier Biomedical Believes This Could Lead To Cancer Cure

January 11, 2016

Premier Biomedical Announces $1.6mil Financing – Consolidates Funding Needs Through 2016

January 5, 2016